Amgen goes solo amid Ukraine fears
Volatility has become the norm in the US high grade new issue market
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: